1. Cytokine changes in LPS-induced TNFα and spontaneous IL-6 production in whole-blood cultures.
Cytokine changes in LPS-induced TNFα and spontaneous IL-6 production in whole-blood cultures. A: LPS-induced TNFα in patients receiving placebo (n = 5). B: LPS-induced TNFα in patients receiving 0.1 mg/kg gevokizumab (n = 5). C: LPS-induced TNFα in patients receiving 0.03 mg/kg gevokizumab (n = 5). D: Dose-response of gevokizumab on LPS-induced TNFα on day 7 in patients treated with gevokizumab. E: Spontaneous production of IL-6 in patients receiving placebo (n = 5). F: Spontaneous production of IL-6 in patients receiving 0.1 mg/kg gevokizumab (n = 5). G: Spontaneous production of IL-6 in patients receiving 0.3 mg/kg gevokizumab (n = 5). H: Dose response of gevokizumab on spontaneous production of IL-6 on day 28. The data are expressed as mean (±SEM) percentage change on days 1, 7, and 28 from baseline levels per million WBCs before the infusion of either placebo or gevokizumab. Details on the calculations are described in research design and methods.
Claudia Cavelti-Weder et al. Dia Care 2012;35:
©2012 by American Diabetes Association